Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Gravistat

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Serum concentration profiles and pharmacokinetic parameters (cmax, tmax, AUC24, AUC0-00, MRT) of ethinylestradiol (EE2) and… Expand
Is this relevant?
1991
1991
Pharmacokinetic investigations (c0h, c2h, c6h, c24h, AUC24) were carried out both in the first and last four days of a treatment… Expand
Is this relevant?
1991
1991
In 8 female sports students (runners) aged 20 and 21 years and 10 women between 20 and 40 years of age, who regularly underwent… Expand
Is this relevant?
1987
1987
The effect of the estrogen-progesteron-combinations Gravistat (0.05 mg ethynylestradiol and 0.125 mg levonorgestrel) on glucose… Expand
Is this relevant?
Review
1987
Review
1987
Hormonal contraceptives may provoke metabolic disturbances in healthy women depending on dosage type of steroid chemical… Expand
Is this relevant?
1986
1986
  • W D Mikrut
  • Wiadomosci lekarskie
  • 1986
  • Corpus ID: 37096055
The author observed 120 women using the contraceptive preparation Gravistat over a 2-year period. The aim of this research was… Expand
Is this relevant?
1980
1980
Reversibility of changes induced by sexual steroids was studied in 19 different serum protein fractions of 20 women. The… Expand
Is this relevant?
1978
1978
In 200 women who on the average 5.6 years took ovosiston and/or non-ovlon, and in 40 women who during the last three months had… Expand
Is this relevant?
1977
1977
In order to check the long-term effects of oral contraceptives used in the GDR on certain serum-lipid-fractions, triglycerides… Expand
Is this relevant?
1977
1977
Total protein fractions in the serum were measured in 213 women who used various contraceptive preparations (53 used Gravistat… Expand
Is this relevant?